No headlines found.
No press releases found.
No news found.
Bristol-Myers Squibb Company Celegne Contingent Value Rights trades on the stock market under the symbol CELG^.
As of April 2, 2026, CELG^ stock price climbed to $0.12 with 17,104 million shares trading.
CELG^ has a beta of -0.67, meaning it tends to be less sensitive to market movements. CELG^ has a correlation of 0.00 to the broad based SPY ETF.
CELG^ has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, CELG^ traded as high as $.27 and as low as $.02.
CELG^ has outperformed the market in the last year with a price return of +151.9% while the SPY ETF gained +17.5%. CELG^ has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +49.9% and +8.5%, respectively, while the SPY returned -3.7% and -0.1%, respectively.
CELG^ support price is $.07 and resistance is $.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELG^ shares will trade within this expected range on the day.
